|
Volumn 19, Issue 5, 2009, Pages 539-540
|
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors?
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SORAFENIB;
SUNITINIB;
CHEMICALLY INDUCED DISORDER;
HUMAN;
HYPOTHYROIDISM;
LETTER;
RISK ASSESSMENT;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
HUMANS;
HYPOTHYROIDISM;
INDOLES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
PYRROLES;
RISK ASSESSMENT;
|
EID: 67650357388
PISSN: None
EISSN: 15579077
Source Type: Journal
DOI: 10.1089/thy.2008.0367 Document Type: Letter |
Times cited : (9)
|
References (0)
|